In the article “Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment” by Muñoz-Lopetegi et al.,1 published online March 2, 2020, the y-axis label for figure 5’s right graph should be “CSF anti-GAD65 concentration (IU/mL).” The editorial office regrets the error.
- © 2020 American Academy of Neurology
Reference
- 1.↵
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Alert Me
Recommended articles
Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease)
Improving accuracy of myasthenia gravis autoantibody testing by reflex algorithm
Infliximab for the treatment of CNS sarcoidosis
Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy